Search Results for Pharmacy Compounding Advisory Committee

Showing 1 – 3

Two-Day FDA Advisory Committee Meeting to Address Drug Compounding Questions By Zachary Brennan - Published 30 September 2015

The US Food and Drug Administration (FDA) will host a two-day public advisory committee meeting on 27 and 28 October to look into updating a list of bulk drug substances that should not be compounded, and another list of substances that can be compounded.

Categories: News, US, FDA, Generic drugs, Prescription drugs, Government affairs, Manufacturing, Postmarket surveillance, Quality, Regulatory intelligence, Regulatory strategy

Tags: drug compounding, fungal meningitis, Pharmacy Compounding Advisory Committee, quinacrine hydrochloride

FDA Considers Compounding Restrictions on Four Drugs, Including Acetaminophen By Alexander Gaffney, RAC - Published 21 May 2015

The US Food and Drug Administration (FDA) is preparing to ask one of its newest advisory committees to decide if some compounding pharmacies should be allowed to make four drugs, including the widely used painkiller acetaminophen.

Categories: News, US, CDER, Drugs

Tags: PCAC, Pharmacy Compounding Advisory Committee, Pharmaceutical Compounding, Compounding

FDA Appoints Members to New, Influential Advisory Committee By Alexander Gaffney, RAC - Published 16 December 2014

Almost a year after announcing the re-creation of its Pharmacy Compounding Advisory Committee (PCAC), the US Food and Drug Administration (FDA) has announced that it has selected 12 experts who will serve on the influential committee as it considers how best to regulate the pharmaceutical compounding sector.

Categories: News, US, CDER, Drugs

Tags: PCAC, Pharmacy Compounding Advisory Committee, Difficult-to-Compound List, AdComm, Advisory Committee